STCUBE
Develops first-in-class immunotherapies targeting BTN1A1 for treatment-resistant cancers.
052020 | KO
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 강남구 영동대로 511 2201(삼성동, 무역센터 트레이드타워), 강남구
- Website:
- https://www.stcube.com/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
STCube is a clinical-stage biopharmaceutical company specializing in the development of first-in-class, precision-driven immunotherapies for cancer. The company's core focus is on its lead drug candidate, Nelmastobart, the world's first immune checkpoint inhibitor targeting the novel BTN1A1 protein. This target is highly expressed in chemo-refractory and resistant cancer cells, often in a mutually exclusive manner with PD-L1, offering a new therapeutic avenue for patients with unmet medical needs. Having successfully completed Phase 1 clinical trials confirming its safety and efficacy, Nelmastobart represents a potential treatment for various treatment-resistant cancers. STCube advances its pipeline through research, development, and biomarker-driven clinical trials, collaborating with leading global institutions and forming strategic partnerships with multinational pharmaceutical companies.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for STCUBE and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Automate Your Workflow. Get a real-time feed of all STCUBE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for STCUBE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
